2022 annual financial data
Immix Biopharma 2022 Financial results
Direct answer
Revenue was -89,517,000 USD.
Operating income was -8,218,948 USD and net income was -8,229,713 USD.
Operating cash flow was -7,408,303 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -89,517,000 USD
- Operating income
- -8,218,948 USD
- Net income
- -8,229,713 USD
- Operating cash flow
- -7,408,303 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immix Biopharma financial years